ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Array Biopharma (ARRY)

Technical Analysis Report for NASDAQ stock ARRY Array Biopharma. Dated: 28 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ARRY Array Biopharma then click here. or read Experts views on Array Biopharma or Forecast & share price targets of Array Biopharma

Array Biopharma Opened at 4.68 and Closed at: 4.59, which is -1.74% of previous session's close. It moved within a range of 4.58 and 4.80
The session was a Bearish session with an average volume of 6577000, which is 15.24% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.
  • The stock has fallen, and its mid term trend is also negative and in a downtrend.
  • The stock has fallen, and its long term trend is also negative and in a downtrend.

A Dead cross was found 9 days back on short term averages

Support for tomorrow is 4.48 and resistance for tomorrow is 4.7
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 4.51, 4.44 resistance for tomorrow's hourly charts is 4.73, 4.88

10 Day SMA for Array Biopharma (ARRY) is 4.72 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Array Biopharma (ARRY) is 5.07 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Array Biopharma (ARRY) is 5.86 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 6.98 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Array Biopharma is 7.93 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Array Biopharma is at 5.07 and 200 DMA is at 7.93, while 50 DMA and 100 DMA are at 5.86 and 6.98 respectively

Array Biopharma (ARRY) moving average of 20 SMA is at 5.07 and 20 EMA is at 5.01

Array Biopharma (ARRY) moving average of 50 SMA is at 5.86 and 50 EMA is at 5.75

Array Biopharma (ARRY) moving average of 100 SMA is at 6.98 and 100 EMA is at 6.6

Array Biopharma (ARRY) moving average of 200 SMA is at 7.93 and 200 EMA is at 7.19

Xenetic Biosciences has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Xenetic Biosciences, about 68.81% more returns!

Bio Techne has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Bio Techne, about 19.48% more returns!

Summit Therapeutics has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Summit Therapeutics, about 24.4% more returns!

Pulse Biosciences has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Pulse Biosciences, about 45.27% more returns!

Array Biopharma has performed better than Nature S in short term. Holding Array Biopharma could be a better choice for now!

Marker Therapeutics has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Marker Therapeutics, about 31.49% more returns!

Ani Pharmaceuticals has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Ani Pharmaceuticals, about 10.16% more returns!

Argenx Se has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Argenx Se, about 42.35% more returns!

Biogen Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Biogen Inc, about 27.45% more returns!

Array Biopharma has performed better than Curis Inc in short term. Holding Array Biopharma could be a better choice for now!

Krystal Biotech has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Krystal Biotech, about 31.63% more returns!

Livanova Plc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Livanova Plc, about 16.59% more returns!

Array Biopharma Technical analysis of indicators

Price action analysis of Array Biopharma (ARRY) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.

MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Array Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Array Biopharma in short term and SELL signal is strong!

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Array Biopharma is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 4.7 and Array Biopharma ARRY stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Array Biopharma ARRY stock. Volume based technical analysis of Array Biopharma ARRY stock is negative.

Array Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock ARRY Array Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ARRY Experts View which covers a lot of information including buying and selling signals

ARRY future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Array Biopharma or View Candle Stick Charts here

Chart Array Biopharma (ARRY)  Technical (Analysis) Reports Array Biopharma [

Videos related to: Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Array Biopharma (ARRY)  Technical (Analysis) Reports Array Biopharma [

 

Back to top